Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 1,142 | 807 | 784 | 308 | 0 |
| Operating Income | -1,142 | -807 | -784 | -308 | N/A |
| Other Income | 4,037 | 2,672 | 1,163 | -64 | 0 |
| Pre-tax Income | 2,896 | 1,865 | 379 | -372 | 0 |
| Net Income Continuous | 2,896 | 1,865 | 379 | -372 | N/A |
| Net Income | $2,896 | $1,865 | $379 | $-372 | $N/A |
| EPS Basic Total Ops | 0.09 | 0.06 | 0.01 | -0.01 | N/A |
| EPS Basic Continuous Ops | 0.46 | 0.30 | 0.06 | -0.06 | N/A |
| EPS Diluted Total Ops | 0.09 | 0.06 | 0.01 | -0.01 | N/A |
| EPS Diluted Continuous Ops | 0.46 | 0.30 | 0.06 | -0.06 | N/A |
| EBITDA(a) | $-1,142 | $-807 | $-784 | $-308 | $N/A |